Skip to content

Tolerance and Benefits of Mandibular Advanced Device for Snoring and Sleep Apnea in Oropharyngeal Cancer.

Sleep Apnea | Snoring | Oral Cancer | Oral Squamous Cell Carcinoma | Pharynx Cancer

Evaluation of the Tolerance and Benefits of Mandibular Advanced Device (MAD) for Snoring and Sleep Apnea in Patients with Oropharyngeal Cancer (OPC): Mixed Design Study.

null

Participation Requirements

  • Sex:

    ALL
  • Eligible Ages:

    18 to 65

Participation Criteria

Inclusion Criteria:

* oropharyngeal cancer diagnosis
* 18 years of age and over
* female or male; ratio of 1/4 toward men
* had received RTH in the Department of Radiation Oncology,
* reporting snoring and/or respiratory cessation complaints during sleep,

Exclusion Criteria:

* pregnant or breastfeeding woman;
* edentation preventing retention of the oral appliance;
* taking opioid or anxiolitic type medications;
* history of major depression,
* uncontrolled hypertension,
* history of stroke;
* under treatment with CPAP for sleep apnea;
* regular and intense orofacial pain;
* under pharmacological treatment for insomnia;
* excessive alcohol or drug use (e.g., cannabis, opioid).

Study Location

CHUM
CHUM
Montréal, Quebec
Canada

Contact Study Team

Primary Contact

Karine Peaupert

514-890-8000
Study Sponsored By
Centre hospitalier de l'Université de Montréal (CHUM)
Participants Required
More Information
Study ID: NCT05719779